AEON Biopharma Inc (AEON) saw an uptrend of 558347% in the recent trading with $898630.0 being its most recent. The current price level -99.72% lower than the highest price of $269.28 marked by the stock while trading over the past 52-weeks, whereas it is 100.80% higher than the lowest price of $0.38 the company dropped to over past 52-weeks. The latest news story on AEON appeared in (GlobeNewswire) under the title “AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711” on May-23-25.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Strong Buy by 1 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.00 for the stock.
AEON Biopharma Inc Earnings – What Happened With AEON
Coming around sales and income figures on AEON Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.
AEON Biopharma Inc – Insider Activity and Holdings
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 10.54 million. AEON does have institutional investors; and they hold 13.50% of the stock.
As on 2024-06-30, ATALAYA CAPITAL MANAGEMENT LP was the top most holder in AEON Biopharma Inc (AMEX:AEON) with an ownership of 3.67 million shares of the company or 680.1022 of the stake worth $3.28 million. The filing also reveals POLAR ASSET MANAGEMENT PARTNERS INC. as the second largest holder in the company with a control over 680.1022 of the outstanding shares. Its stake is worth $3.27 million for having 3.67 million shares in hand.
VANGUARD GROUP INC also came holding a key position in the company during the recent quarter and it now holds 139.0449 of the outstanding shares. With this there are now 19.0 institutions which have possession in AEON’s shares.
Key Metrics forAEON
Technical Analysis of AEON Biopharma Inc (AMEX:AEON) stock
To comprehend better with the trade moves and investors’ behavior, exploring the short, medium and long term technical indicators along with average volume of a stock is an effective way to make use of. When looking into those indicators for AEON Biopharma Inc (AEON), we notice that the stock’s 20-day average volume is at 494,245 shares. Medium term indicators at an average of 50% are spotting the stock at Sell with its 50-day average volume of 975,346 shares. And to end, AEON’s 100-day average volume is 2,405,739 shares with 100% of the long-term indicators pointing towards Sell for the stock.
